Cargando…
Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
Previous reports have shown that expression of BARD1δ, a deletion-bearing isoform of BARD1, correlates with tumor aggressiveness and progression. We show that expression of BARD1δ induces cell cycle arrest in vitro and in vivo in non-malignant cells. We investigated the mechanism that leads to proli...
Autores principales: | Pilyugin, Maxim, André, Pierre-Alain, Ratajska, Magdalena, Kuzniacka, Alina, Limon, Janusz, Tournier, Benjamin B., Colas, Julien, Laurent, Geoff, Irminger-Finger, Irmgard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354735/ https://www.ncbi.nlm.nih.gov/pubmed/28030839 http://dx.doi.org/10.18632/oncotarget.14068 |
Ejemplares similares
-
BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer
por: Pilyugin, Maxim, et al.
Publicado: (2021) -
Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example
por: Klonowska, Katarzyna, et al.
Publicado: (2015) -
BARD1 serum autoantibodies for the detection of lung cancer
por: Pilyugin, Maxim, et al.
Publicado: (2017) -
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
por: Ratajska, Magdalena, et al.
Publicado: (2012) -
Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome
por: Zhang, Y-Q, et al.
Publicado: (2012)